drugset / Trial / NCT06574555

Norepinephrine ED90 Bolus After Spinal Anesthesia in Cesarean Section

NCT06574555

Phase 4 Completed 60 enrolled Pontificia Universidad Catolica de Chile
RandomizedSequentialTriple-blindPrevention

Summary

The investigators are aiming to determine what is the effective intravenous dose required of an initial bolus of norepinephrine prior to a maintenance infusion to prevent a 20% decrease in maternal blood pressure from baseline following the administration of spinal anesthesia for elective cesarean section in healthy parturients

Timeline

Start
2025-04-01
Primary completion
2025-08-01
Completion
2025-08-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Norepinephrine Other / unclassified 0.13 ug/kg Intravenous
Subject Norepinephrine Other / unclassified 0.15 ug/kg Intravenous